Similar articles

• Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.

  Guillén FJ, Ferrara J, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF. Guillén FJ, et al. Lab Invest. 1986 Jul;55(1):35-42. Lab Invest. 1986. PMID: 3523039
• Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.

  Ferrara JL, Daley JP, Burakoff SJ, Miller RA. Ferrara JL, et al. J Immunol. 1987 Jun 1;138(11):3598-603. J Immunol. 1987. PMID: 3108369
• T cell subsets and graft-versus-host disease.

  Korngold R, Sprent J. Korngold R, et al. Transplantation. 1987 Sep;44(3):335-9. doi: 10.1097/00007890-198709000-00002. Transplantation. 1987. PMID: 2957834 No abstract available.
• [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].

  Clerici M, Villa ML, Clerici E. Clerici M, et al. Boll Ist Sieroter Milan. 1988;67(3):177-96. Boll Ist Sieroter Milan. 1988. PMID: 3072013 Review. Italian.
• Lethal graft-versus-host disease across minor histocompatibility barriers in mice.

  Korngold R, Sprent J. Korngold R, et al. Clin Haematol. 1983 Oct;12(3):681-93. doi: 10.1016/s0308-2261(83)80005-8. Clin Haematol. 1983. PMID: 6416727 Review. No abstract available.